Skip to content ↓

Strehle to speak on investing

What are reasonable investment expectations for the future? That's a daunting question these days, but Treasurer Emeritus Glenn Strehle will tackle it in a seminar on Tuesday, Oct. 23 at 10 a.m. in the Bush Room (10-105).

The seminar, "Living with Stocks in a Down Market," was arranged by the Association of MIT Retirees but is open to the community.

Strehle will address questions such as how we should react when market prices decline and what we know about today's securities markets. There will be ample opportunity for questions.

Strehle (S.B. 1958, S.M.) was treasurer of MIT from 1975-98. During the first 10 years, he was MIT's chief investment officer, guiding the investment activities of the Institute and its retirement plans. He also headed the Office of Resource Development and the successful "Campaign for the future." In 1986 he assumed the additional title of vice president for finance.

Strehle is a chartered financial analyst and was a portfolio manager at a Boston investment company before returning to MIT. He is a former president of the Boston Security Analysts Society and the Boston Economic Club.

Retirees who need parking assistance should call the Retiree's office at x3-7910 for assistance.

A version of this article appeared in MIT Tech Talk on October 17, 2001.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story